107 related articles for article (PubMed ID: 23046493)
1. Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Aramaki T; Moriguchi M; Bekku E; Asakura K; Sawada A; Endo M
Hepatol Res; 2013 May; 43(5):475-80. PubMed ID: 23046493
[TBL] [Abstract][Full Text] [Related]
2. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Miyayama S; Yamashiro M; Shibata Y; Hashimoto M; Yoshida M; Tsuji K; Toshima F; Matsui O
Jpn J Radiol; 2012 Apr; 30(3):263-70. PubMed ID: 22223074
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.
Tawada A; Chiba T; Ooka Y; Kanogawa N; Saito T; Motoyama T; Ogasawara S; Suzuki E; Kanai F; Yoshikawa M; Yokosuka O
Anticancer Res; 2015 Jan; 35(1):549-54. PubMed ID: 25550601
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin.
Handa T; Imai Y; Sugawara K; Chikayama T; Nakazawa M; Ando S; Hamaoka K; Inao M; Nakayama N; Mochida S
Hepatol Res; 2014 Oct; 44(11):1072-80. PubMed ID: 23957866
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma.
Kubota K; Hidaka H; Nakazawa T; Okuwaki Y; Yamane K; Inoue T; Uojima H; Takada J; Tanaka Y; Shibuya A; Fujii K; Woodhams R; Matsunaga K; Kokubu S; Koizumi W
Hepatol Res; 2018 Feb; 48(3):E98-E106. PubMed ID: 28656607
[TBL] [Abstract][Full Text] [Related]
6. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
[TBL] [Abstract][Full Text] [Related]
7. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results.
Ogawa M; Takayasu K; Hirayama M; Miura T; Shiozawa K; Abe M; Matsumoto N; Nakagawara H; Ohshiro S; Yamamoto T; Tanaka N; Moriyama M; Mutou H; Yamamoto Y; Irie T
Hepatol Res; 2016 Mar; 46(3):E60-9. PubMed ID: 25974615
[TBL] [Abstract][Full Text] [Related]
9. Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy.
Hashimoto N; Iwazawa J; Ohue S; Mitani T
Onco Targets Ther; 2013; 6():1025-30. PubMed ID: 23986641
[TBL] [Abstract][Full Text] [Related]
10. Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin.
Iwazawa J; Ohue S; Hashimoto N; Mitani T
Cancer Manag Res; 2012; 4():113-9. PubMed ID: 22570565
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma.
Seko Y; Ikeda K; Kawamura Y; Fukushima T; Hara T; Sezaki H; Hosaka T; Akuta N; Suzuki F; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Kumada H
Hepatol Res; 2013 Sep; 43(9):942-9. PubMed ID: 23301851
[TBL] [Abstract][Full Text] [Related]
12. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
13. Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma.
Ishikawa T; Abe S; Watanabe T; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T
Mol Clin Oncol; 2016 Nov; 5(5):511-516. PubMed ID: 27882236
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma.
Ueda T; Murata S; Yasui D; Mine T; Kumita S
Hepatol Res; 2013 Oct; 43(10):1071-7. PubMed ID: 23905645
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma.
Ikeda K; Kawamura Y; Kobayashi M; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Hepatol Res; 2017 Jun; 47(7):632-640. PubMed ID: 27487085
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.
Ikeda M; Kudo M; Aikata H; Nagamatsu H; Ishii H; Yokosuka O; Torimura T; Morimoto M; Ikeda K; Kumada H; Sato T; Kawai I; Yamashita T; Horio H; Okusaka T;
J Gastroenterol; 2018 Feb; 53(2):281-290. PubMed ID: 28766016
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
20. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
